Plant and equipment sit at the core of pharmaceutical and plastics manufacturing operations.
From precision fill-finish lines to advanced moulding and extrusion systems, these assets represent significant capital investment. When managed strategically, they can deliver value well beyond their initial operational life.
As global supply chains tighten and production timelines extend, manufacturers are reassessing how they acquire, redeploy, and monetise specialised equipment across its lifecycle.
In both sectors, equipment value is shaped by precision engineering, regulatory compliance, and production capability.
Assets such as blow-fill-seal machines, aseptic packaging lines, injection moulders, and extrusion systems are built to high standards. As a result, they often remain in demand well beyond their first use.
Long lead times for new machinery also increase reliance on secondary markets. These markets allow manufacturers to access proven equipment more quickly and often at a lower cost.
A recent project highlights how specialist equipment can be repositioned in global markets.
Following the closure of a pharmaceutical production facility, Hilco APAC was engaged to manage the valuation, marketing, and sale of complex manufacturing assets. This included advanced blow-fill-seal equipment, which attracted strong international interest and delivered strong sales outcomes.
By combining market-based valuation with targeted global marketing, the assets were redeployed efficiently. This supported the seller in maximising value while enabling buyers to secure critical equipment without extended lead times.
For pharmaceutical and plastics manufacturers, secondary markets provide clear advantages:
For asset owners, a structured monetisation approach ensures surplus or idle equipment is positioned to achieve appropriate market value.
Maximising returns from plant and equipment requires sector knowledge and an understanding of global demand.
Accurate valuation, targeted buyer outreach, and compliance-aware execution are essential, particularly in regulated environments.
Working with specialists who understand both the assets and their markets allows organisations to make more informed decisions and manage complexity with greater confidence.
Plants and equipment remain central to pharmaceutical and plastics manufacturing, not only in production but as strategic assets throughout their lifecycle.
With the right expertise and global reach, these assets can continue to deliver value at every stage.
Have an excess, obsolete or returned stock challenge? Talk to us.
Rochelle has forged a career as a Retail inventory specialist over 18 years across auctions, marketplaces, eCommerce and Retail, locally and internationally. Having worked for both high growth start-ups and Australia’s largest retail corporations, Rochelle has seen the myriad of challenges faced by Retailers in complex inventory environments.
As Director, Wholesale at Hilco Global, Rochelle translates this expertise in buying, sourcing and trading, offering clients strategies that can be deployed immediately in solving inventory challenges at scale.
"*" indicates required fields
